Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 24, 2017
Pharmacy Choice - Pharmaceutical News - Lupin receives final USFDA approval for two drugs [India Infoline News Service] - July 24, 2017

Pharmacy News Article

 2/16/17 - Lupin receives final USFDA approval for two drugs [India Infoline News Service]

Lupin, has announced that the Company has received USFDA approval. The approval is for ANDA Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution (Syrup), 5 mg/1.5 mg per 5 ml, which is a generic version of Hycodan Oral Solution, 5 mg/1.5 mg per 5 mL, manufactured by Endo Pharmaceuticals, Inc. Lupin, has announced that the Company has received USFDA approval. The approval is for ANDA Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution (Syrup), 5 mg/1.5 mg per 5 ml, which is a generic version of Hycodan Oral Solution, 5 mg/1.5 mg per 5 mL, manufactured by Endo Pharmaceuticals, Inc.

The stock in a period of one year has delivered negative returns of 17.99%, underperforming the BSE Sensex and the BSE Healthcare index over the same time span.

Lupin Limited is a transnational pharmaceutical company based in Mumbai. It is the seventh-largest company by market capitalisation and the 10th-largest generic pharmaceutical company by revenue, globally.

Stock view:-

Lupin Ltd is currently trading at Rs 1440.15, up by Rs 8.15 or 0.57% from its previous closing of Rs 1432 on the BSE.

The scrip opened at Rs 1437 and has touched a high and low of Rs 1448.8 and Rs 1425 respectively. So far 1300888(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 64654.13 crore.

The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 1874.3 on 14-Mar-2016 and a 52 week low of Rs 1294.05 on 29-Mar-2016. Last one week high and low of the scrip stood at Rs 1520 and Rs 1428 respectively.

The promoters holding in the company stood at 46.71 % while Institutions and Non-Institutions held 41.46 % and 11.83 % respectively.

The stock is currently trading below its 200 DMA.



(c) 2017India Infoline Ltd. All rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Jul 24: What's New? New Treatments for Type 2 Diabetes
Jul 26: Management of Schizophrenia & Acute Agitation
Jul 27: On the Move: A Comprehensive Review of Osteoarthritis, Gout & Rheumatoid Arthritis
Jul 31: Obesity Management: Overview of Pharmacotherapy
Aug 01: Treatment of Depression and Anxiety in Older Adults
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415